Covered recipient · General Payments record
YE ELAINE WANG
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$45,294.83
- Reported across 187 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,185.61 | 31 |
| Consulting Fee | $1,050.00 | 1 |
| Honoraria | $500.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Thea Pharma Inc. | $1,112.97 | 5 |
| ABBVIE INC. | $534.92 | 12 |
| Iridex Corporation | $520.22 | 2 |
| Sight Sciences, Inc. | $393.56 | 8 |
| GLAUKOS CORPORATION | $120.83 | 3 |
| Alcon Laboratories Inc | $38.57 | 2 |
| Bausch & Lomb Americas Inc. | $14.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.90 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307363 | CMS |
| ABBVIE INC. | $95.54 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307365 | CMS |
| ABBVIE INC. | $33.57 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307367 | CMS |
| ABBVIE INC. | $27.88 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307369 | CMS |
| ABBVIE INC. | $31.04 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307371 | CMS |
| ABBVIE INC. | $32.80 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307373 | CMS |
| ABBVIE INC. | $33.18 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307375 | CMS |
| ABBVIE INC. | $31.44 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307377 | CMS |
| ABBVIE INC. | $34.98 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307379 | CMS |
| ABBVIE INC. | $25.02 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307381 | CMS |
| ABBVIE INC. | $34.57 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307383 | CMS |
| ABBVIE INC. | $125.00 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106307385 | CMS |
| Alcon Vision LLC | $24.75 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110621745 | CMS |
| Alcon Vision LLC | $13.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110621743 | CMS |
| Bausch & Lomb Americas Inc. | $14.54 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140468675 | CMS |
| Glaukos Corporation | $21.41 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151981726 | CMS |
| Glaukos Corporation | $43.19 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151977952 | CMS |
| Glaukos Corporation | $56.23 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151977954 | CMS |
| Iridex Corporation | $20.22 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154798467 | CMS |
| Iridex Corporation | $500.00 | 05/02/2024 | Honoraria | Undisputed | 01/23/2026 | 1154798527 | CMS |
| Sight Sciences, Inc. | $147.85 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151919606 | CMS |
| Sight Sciences, Inc. | $15.58 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931929 | CMS |
| Sight Sciences, Inc. | $13.52 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931927 | CMS |
| Sight Sciences, Inc. | $46.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931935 | CMS |
| Sight Sciences, Inc. | $19.12 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931933 | CMS |
| Sight Sciences, Inc. | $16.13 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931931 | CMS |
| Sight Sciences, Inc. | $10.36 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151933235 | CMS |
| Sight Sciences, Inc. | $125.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151932129 | CMS |
| Thea Pharma Inc. | $19.73 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545579 | CMS |
| Thea Pharma Inc. | $10.42 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545581 | CMS |
| Thea Pharma Inc. | $9.93 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545583 | CMS |
| Thea Pharma Inc. | $1,050.00 | 09/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1074545585 | CMS |
| Thea Pharma Inc. | $22.89 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545587 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.